Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109180564A reveals a robust synthesis route for fluorinated piperidines offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105218606B details a phenol-based route for scutellarin. Offers high purity and scalable manufacturing for cardiovascular drug intermediates.
Novel preparation method of Topiroxostat using 4-cyanopyridine and isonicotinic acid. High yield, low cost, suitable for industrial scale-up.
Patent CN108026007A reveals Mo-doped Raney Ni catalyst for high-purity diol synthesis. Enables cost reduction in synthetic flavors manufacturing with safer moderate conditions.
Patent CN115215835A reveals a high-yield two-step Negishi coupling route for isoindoline intermediates, offering significant cost and safety advantages for API manufacturing.
Novel patent CN114685593B offers column-free fulvestrant synthesis. Solid intermediates ensure supply chain stability and cost reduction for pharmaceutical manufacturers seeking reliable partners.
Patent CN117552021A reveals metal-free electrocatalytic synthesis. Delivers high-purity sulfonylated BODIPYs with green manufacturing and supply chain advantages.
Patent CN116003384A reveals a novel synthetic route for dabigatran intermediates featuring early-stage cyclization and NHPI oxidation for superior yield and purity.
Patent CN114516877B reveals safer route for PARP inhibitor intermediate with high purity and reduced safety risks for supply chain.
Patent CN102348691A details a high-yield process for quinolinone derivatives, replacing DMSO with xylene to drastically reduce impurities and enhance supply chain reliability for API manufacturing.
Novel iron-catalyzed method avoids palladium toxicity. Enhances safety and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Novel safe route for antitumor drug intermediate. High yield, low cost, scalable process replacing hazardous nitration methods.
Electrochemical synthesis of selenium compounds offers high yield and scalability. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN101575298B details a cost-effective synthesis of chiral 2-amino-1-phenylethylalcohol from styrene glycol, offering high optical purity for beta-agonist manufacturing.
New one-step synthesis method for Oxiracetam intermediate. High yield, low waste, scalable production for pharmaceutical supply chains.
Patent CN111704555B reveals continuous flow method for 4-methoxy-2-nitroaniline. High purity, safety, cost reduction for pharma intermediates.
Patent CN113248458B details a green CuI-catalyzed oxidative amidation. Offers cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Patent CN115557824A reveals a green palladium-catalyzed route for aryl alkynes using carboxylic acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel nitration route avoids chlorosulfonic acid hazards ensuring safer scalable production and cost reduction for pharmaceutical intermediates supply chains.
Novel patent CN116496239A offers a green synthesis route for Venetoclax intermediates, ensuring high purity and supply chain reliability for global pharmaceutical procurement.